Copenhagen, Denmark, and Davis, California, – 21st.BIO, a leading provider of precision fermentation technology, announces a major safety milestone with the publication of a peer-reviewed study showcasing the world’s first fully mycotoxin-free Aspergillus oryzae strain lineage for industrial protein production. The breakthrough further strengthens the foundation for cost-effective production of novel food proteins at scale using filamentous fungi. Redefining the gold standard in … [Read more...] about 21st.BIO establishes a new gold standard in precision fermentation for safe novel protein production
21st.BIO
21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally
21st.BIO unveiled a new pilot plant facility in its Danish headquarters, designed to support companies upscale their bioproduction. 21st.BIO provides services ranging from strain construction to industrial production upscaling to customers worldwide. Combining world-class industrially proven technology with fermentation capacity, the company will help customers get to scale faster, in a risk-mitigated and cost-effective way. Why do we need pilot facilities? Upscaling … [Read more...] about 21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally
21st.BIO Opens a More Sustainable Avenue for Industrial-Scale Dairy Protein Production
COPENHAGEN, Denmark, and DAVIS, Calif., USA, 31 January 2024 – Global bioproduction leader 21st.BIO today announced it is granting access to its precision fermentation technology platform to ingredient manufacturers enabling the production of dairy proteins at competitive cost. This follows 21st.BIO’s successful scaling of the beta-lactoglobulin protein, a major protein in milk that provides highly valuable nutrition and textural components of milk and other dairy ingredients. By offering its … [Read more...] about 21st.BIO Opens a More Sustainable Avenue for Industrial-Scale Dairy Protein Production
